Dexcom traded at $108.43 this Friday February 3rd, increasing $0.40 or 0.37 percent since the previous trading session. Looking back, over the last four weeks, Dexcom gained 5.16 percent. Over the last 12 months, its price rose by 3.18 percent. Looking ahead, we forecast Dexcom to be priced at 104.87 by the end of this quarter and at 94.89 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
108.43
Daily Change
0.37%
Yearly
3.18%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abbott 111.79 -0.46 -0.41% -13.82%
Align Technology 343.10 -16.78 -4.66% -29.96%
AtriCure 47.20 -0.02 -0.04% -26.78%
Avanos Medical Inc 31.59 -0.16 -0.50% 7.38%
Baxter International 46.68 -0.33 -0.70% -46.17%
Becton, Dickinson and Co. 245.84 -2.63 -1.06% -8.56%
Boston Scientific 48.50 0.43 0.89% 13.40%
Cooper Companies 354.49 -8.04 -2.22% -8.79%
Cardiovascular Systems 14.72 0.06 0.41% -17.21%
Dexcom 108.43 0.40 0.37% 3.18%
Edwards Lifesciences 82.12 -2.39 -2.83% -26.80%
Globus Medical 79.63 1.04 1.32% 19.39%
Hologic 84.68 0.24 0.28% 13.30%
Integra LifeSciences 59.61 -0.88 -1.45% -7.88%
Inogen 26.00 0.31 1.21% -11.56%
J&J 164.61 -0.93 -0.56% -4.09%
Masimo 169.45 -5.27 -3.02% -23.79%
Medtronic 87.10 -0.48 -0.55% -15.21%
Merit Medical Systems 73.33 -0.09 -0.12% 33.30%
NuVasive 48.12 0.43 0.90% -4.09%
Insulet 295.19 2.24 0.76% 21.23%
Roche Holding 282.95 9.10 3.32% -18.04%
Sientra 1.93 -0.12 -5.85% -28.78%
Stryker 283.14 0.66 0.23% 12.83%
Teleflex 258.47 -3.75 -1.43% -17.50%
Tandem Diabetes Care 45.04 0.06 0.13% -61.55%
West Pharmaceutical Services 272.88 -9.00 -3.19% -31.91%
Zimmer Biomet Holdings Inc 129.45 2.04 1.60% 5.39%

Indexes Price Day Year
USND 12007 -193.86 -1.59% -14.83%
US2000 1986 -15.69 -0.78% -0.84%
USNDX 12504 -229.78 -1.79% -14.19%
US500 4117 -43.28 -1.04% -8.18%

Dexcom
Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.